Sangamo BioSciences (SGMO -3.7%) stabilizes after a volatile opening this morning, albeit lower,...

|About: Sangamo BioSciences, Inc. (SGMO)|By:, SA News Editor

Sangamo BioSciences (SGMO -3.7%) stabilizes after a volatile opening this morning, albeit lower, after announcing the presentation of encouraging new clinical data from its program to develop a ZFP Therapeutic for HIV/AIDS. The data, which demonstrates that SB-728-T treatment results in a reduction in the HIV reservoir in HIV-infected subjects, is being presented at the 16th Annual Meeting of the American Society of Gene and Cell Therapy.